Eloxx Pharmaceuticals Statistics
Total Valuation
ELOX has a market cap or net worth of $31.87 million. The enterprise value is $43.29 million.
| Market Cap | 31.87M |
| Enterprise Value | 43.29M |
Important Dates
The last earnings date was Monday, November 13, 2023, after market close.
| Earnings Date | Nov 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ELOX has 3.44 million shares outstanding. The number of shares has increased by 908.65% in one year.
| Current Share Class | 3.44M |
| Shares Outstanding | 3.44M |
| Shares Change (YoY) | +908.65% |
| Shares Change (QoQ) | +1,166.84% |
| Owned by Insiders (%) | 4.55% |
| Owned by Institutions (%) | 0.42% |
| Float | 532,091 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 118.82% |
| Weighted Average Cost of Capital (WACC) | -703,872.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$804,000 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +772,627.27% in the last 52 weeks. The beta is -167,970.40, so ELOX's price volatility has been lower than the market average.
| Beta (5Y) | -167,970.40 |
| 52-Week Price Change | +772,627.27% |
| 50-Day Moving Average | 2.37 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 59.24 |
| Average Volume (20 Days) | 18,715 |
Short Selling Information
The latest short interest is 21,485, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 21,485 |
| Short Previous Month | 42,744 |
| Short % of Shares Out | 0.63% |
| Short % of Float | 4.04% |
| Short Ratio (days to cover) | 1.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.01M |
| Pretax Income | -8.04M |
| Net Income | -8.04M |
| EBITDA | n/a |
| EBIT | -9.01M |
| Earnings Per Share (EPS) | -$3.77 |
Balance Sheet
The company has $6.36 million in cash and $11.82 million in debt, with a net cash position of -$5.46 million or -$1.59 per share.
| Cash & Cash Equivalents | 6.36M |
| Total Debt | 11.82M |
| Net Cash | -5.46M |
| Net Cash Per Share | -$1.59 |
| Equity (Book Value) | -7.58M |
| Book Value Per Share | -16.44 |
| Working Capital | -7.58M |
Cash Flow
| Operating Cash Flow | -12.98M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 2.18M |
| Free Cash Flow | -12.98M |
| FCF Per Share | -$3.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELOX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -908.65% |
| Shareholder Yield | -908.65% |
| Earnings Yield | -21.25% |
| FCF Yield | -34.32% |
Analyst Forecast
The average price target for ELOX is $330.00, which is 3,457.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $330.00 |
| Price Target Difference | 3,457.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2026. It was a reverse split with a ratio of 1:11.
| Last Split Date | Jun 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:11 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |